NISHP Double Feature
Part 1
Overview of Oritavancin (Orbactiv)
Presented By:
Larry H. Danziger, PharmD, FIDSA
Professor
Co-Director, Section of Infectious Diseases Pharmacotherapy
Executive Director, Center for Advanced Research, Design and Exploration
Office of the Vice Chancellor for Research
University of Illinois at Chicago College of Pharmacy
Chicago, IL
Registration and dinner will begin at 6:00 pm
Presentation will be 6:30 pm - 7:15 pm
This program is free to ICHP members. However, those who do not attend and do not cancel at least 48 hours prior to the program will be charged $20.00 to cover expenses.
Pre-registration is required. Please bring a copy of your email registration confirmation with you to the meeting.
When registering, you MUST indicate which part you will be attending - Part 1, Part 2, or both Part 1 & Part 2.
This non-CE program is sponsored by The Medicines Company.
Part 2
Hypertension Guidelines Have Your Blood Pressure Up?Presented By:Diana Isaacs, Pharm.D., BCPS, BC-ADM
Clinical Pharmacy Specialist, Ambulatory Care; Assistant Professor
Chicago State University, Chicago, IL
Date & Time:Wednesday, January 21, 2015
7:15 - 7:30 Registraton for CPE presentation
7:30 pm - 8:30 pm CPE Presentation
Registration: Registration is now closed. Registration deadline is Friday, January 16 at 9:00 am.
This program is free to ICHP members. However, those who do not attend
and do not cancel at least 48 hours prior to the program will be charged
$20.00 to cover expenses.
Pre-registration is required. Please bring a copy of your email registration confirmation with you to the meeting.
When registering, you MUST indicate which part you will be attending - Part 1, Part 2, or both Part 1 & Part 2.
PLEASE NOTE: If you received credit for this program at the 2014 ICHP Annual Meeting, you will not be able to resubmit for additional credit.
Location:Reel Club
272 Oakbrook Center
Oakbrook, IL 60523
Learning Objectives:At the end of this presentation, pharmacist participants should be able to:
1. Discuss the most recent hypertension guidelines including JNC8 and the American Society of Hypertension/International Society of Hypertension.
2. Describe how the current guidelines differ between previous guidelines and other organization guidelines and what evidence exists for these changes.
3. Identify blood pressure goals and recommended drug therapy for special populations including the elderly, African Americans, patients with diabetes, and patients with chronic kidney disease.
At the end of this presentation, technician participants should be able to:
1. Define hypertension.
2. Identify drug classes used to treat hypertension.
3. Define blood pressure goals for specified patient populations.
Accreditation: 
ACPE # 0121-0000-14-071-L01-P; 0121-0000-14-071-L01-T
0.1 Contact Hour (0.1 CEU) Type of Activity: Knowledge-based
This Northern Illinois Society of Health-System Pharmacists (NISHP) program is sponsored by the Illinois Council of Health-System Pharmacists (ICHP). ICHP is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Faculty Disclosure: It is the policy of the Illinois Council of Health-System Pharmacists (ICHP) to ensure balance, independence, objectivity, and scientific rigor in all of its education programs. In accordance with this policy, faculty must disclose to the participants any significant relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of these continuing pharmacy education programs. These disclosures will be available at the program.
Attendees must complete a program evaluation online and may immediately print their statements of continuing pharmacy education credit at
www.CESally.com.
Target Audience: Health-System Pharmacists and Technicians
What is CPE Monitor and why do I need a NAPB e-Profile ID number?CPE Monitor is a national, collaborative effort by the National Association of Boards of Pharmacy (NABP) and the Accreditation Council for Pharmacy Education (ACPE) to provide an electronic system for pharmacists and pharmacy technicians to track their completed continuing pharmacy education (CPE) credits. It will also offer state boards of pharmacy the opportunity to electronically authenticate the CPE units completed by their licensees, rather than requiring pharmacists and technicians to submit their proof of completion statements upon request or for random audits.
Click here to learn more and obtain your NABP e-Profile ID number.NEW - PTCB now requires CPhTs to earn only pharmacy technician-specific (‘T-specific’) credit to qualify for recertification. However, any Pharmacist or P-specific credit earned by technicians in 2014 will still be accepted for those recertifying in 2015. As of January 1, 2015, ALL CPE credit earned must be T-specific. In addition, PTCB will reduce the number of allowable CPE hours earned through in-service training from 10 to 5. Please advise all pharmacy technicians at your site of this change.
